Cargando…

PR3-ANCA: A Promising Biomarker in Primary Sclerosing Cholangitis (PSC)

BACKGROUND AND AIMS: The only recognized biomarker for primary sclerosing cholangitis (PSC) is atypical anti-neutrophil cytoplasmic antibodies (aANCA), which, in addition to having low sensitivity and specificity, is an indirect immunofluorescence (IIF) test lacking the advantages of high throughput...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stinton, Laura M., Bentow, Chelsea, Mahler, Michael, Norman, Gary L., Eksteen, Bertus, Mason, Andrew L., Kaplan, Gilaad G., Lindkvist, Bjorn, Hirschfield, Gideon M., Milkiewicz, Piotr, Cheung, Angela, Janssen, Harry L. A., Fritzler, Marvin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232573/ https://www.ncbi.nlm.nih.gov/pubmed/25397578 http://dx.doi.org/10.1371/journal.pone.0112877

Ejemplares similares

Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis
por: Wunsch, Ewa, et al.
Publicado: (2020)

PR3-ANCAs Detected by Third-Generation ELISA Predicts Severe Disease and Poor Survival in Primary Sclerosing Cholangitis
por: Lopens, Steffi, et al.
Publicado: (2022)

Primary Sclerosing Cholangitis With Features of Autoimmune Hepatitis: Exploring the Global Variation in Management
por: Milkiewicz, Piotr, et al.
Publicado: (2020)

Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study
por: Bowlus, Christopher L., et al.
Publicado: (2023)

British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis
por: Chapman, Michael Huw, et al.
Publicado: (2019)

Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study
por: Eksteen, Bertus, et al.
Publicado: (2020)

Detection of autoantibodies using chemiluminescence technologies
por: Mahler, Michael, et al.
Publicado: (2016)

Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet-based survey
por: Bentow, Chelsea, et al.
Publicado: (2016)

Intrahepatic macrophage populations in the pathophysiology of primary sclerosing cholangitis
por: Chen, Yung-Yi, et al.
Publicado: (2019)

Significance of Autoantibodies to Ki/SL as Biomarkers for Systemic Lupus Erythematosus and Sicca Syndrome
por: Mahler, Michael, et al.
Publicado: (2022)

Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis
por: Milkiewicz, Malgorzata, et al.
Publicado: (2016)

Oncomir MicroRNA-346 Is Upregulated in Colons of Patients With Primary Sclerosing Cholangitis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2020)

Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2021)

Hepatic Endothelial CCL25 Mediates the Recruitment of CCR9(+) Gut-homing Lymphocytes to the Liver in Primary Sclerosing Cholangitis
por: Eksteen, Bertus, et al.
Publicado: (2004)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center Study
por: Norman, Gary L., et al.
Publicado: (2019)

Deciphering the Autoantibody Response to the OJ Antigenic Complex
por: Fritzler, Marvin J., et al.
Publicado: (2023)

Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC)
por: Mattner, Jochen
Publicado: (2016)

The PSC scientific community resource: an asset for multi-omics interrogation of primary sclerosing cholangitis
por: Ali, Ahmad Hassan, et al.
Publicado: (2021)

Surveillance imaging in primary sclerosing cholangitis (PSC): evidence, patient preference and physician autonomy
por: Berry, Philip A., et al.
Publicado: (2022)

A212 LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS (PSC): EXPERIENCE FROM THE LAST THREE DECADES
por: Zhu, J, et al.
Publicado: (2022)

Frequency and significance of IgG4 immunohistochemical staining in liver explants from patients with primary sclerosing cholangitis
por: Fischer, Sandra, et al.
Publicado: (2014)

The immunobiology of primary sclerosing cholangitis
por: Aron, Jonathan H., et al.
Publicado: (2009)

Mast Cells in Immune-Mediated Cholangitis and Cholangiocarcinoma
por: González, Marisol I., et al.
Publicado: (2022)

Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis–Inflammatory Bowel Disease
por: Chung, Brian K., et al.
Publicado: (2018)

IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019)

NLRP3 receptor contributes to protection against experimental antigen-mediated cholangitis
por: González, Marisol Ibet, et al.
Publicado: (2020)

ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2017)

The Primary Sclerosing Cholangitis (PSC) Wellbeing Study: Understanding psychological distress in those living with PSC and those who support them
por: Ranieri, Veronica, et al.
Publicado: (2020)

Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984)

Primary sclerosing cholangitis
por: Worthington, Joy, et al.
Publicado: (2006)

A210 HEPATOLITHIASIS IS A FREQUENT AND PROGNOSTIC FINDING IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
por: Jubran, B, et al.
Publicado: (2022)

Modulation of Mismatch Repair and the SOCS1/p53 Axis by microRNA-155 in the Colon of Patients with Primary Sclerosing Cholangitis
por: Adamowicz, Monika, et al.
Publicado: (2022)

Association between Air Pollution and the Development of Rheumatic Disease: A Systematic Review
por: Sun, Gavin, et al.
Publicado: (2016)

Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis – A review of cholangiographic and ultrasound imaging
por: Möller, Kathleen, et al.
Publicado: (2022)

A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
por: Kowdley, Kris V., et al.
Publicado: (2020)

Neutralization of IL-15 abrogates experimental immune-mediated cholangitis in diet-induced obese mice
por: Reyes, José L., et al.
Publicado: (2018)

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis
por: Trauner, Michael, et al.
Publicado: (2019)

Primary Sclerosing Cholangitis: Palliative Surgery or Transplantation?
por: Cameron, John L.
Publicado: (1992)

Pathogenesis of primary sclerosing cholangitis
por: Pollheimer, Marion J., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b071t2mc2u4a1snibgocuc6v3b